Clinical Trial Update: Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating carvedilol to prevent heart failure in childhood cancer survivors has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Children's Oncology Group | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2023-09-29